Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Nov 8;91(23):11202-6.
doi: 10.1073/pnas.91.23.11202.

Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase

Affiliations

Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase

R A Copeland et al. Proc Natl Acad Sci U S A. .

Abstract

Selective inhibition of the inducible isoform of prostaglandin G/H synthase (cyclooxygenase-2; COX2; EC 1.14.99.1) can be achieved with compounds of the general form of aryl methyl sulfonyls and aryl methyl sulfonamides. DuP 697 and NS-398 are representative examples of these compounds. Both inhibit the constitute (COX1) and inducible (COX2) isoforms of the enzyme with equal potency shortly after mixing, but their potencies increase with time for COX2 selectively. This time-dependent inhibition follows first-order kinetics, and the rate constant for inactivation of COX2 is dose dependent for both compounds. Kinetic analysis allows us to determine KI and kinact (the maximal rate of inactivation) for each inhibitor. The potency of both compounds is substrate concentration dependent, as expected for time-dependent competitive inhibitors. COX2 that has been incubated with these inhibitors, and then extensively dialyzed against buffer, shows no recovery of enzyme activity, while complete recovery of activity is seen for COX1. Thus, these inhibitors irreversibly inactivate COX2 with time, while showing minimal reversible inhibition of COX1. We isolated these inhibitors after long incubation with excess enzyme and subsequent denaturation of the enzyme. Both inhibitors showed no loss of potency resulting from interactions with COX2, suggesting that inhibition is not mediated by covalent modification of the enzyme. These data suggest that binding of these inhibitors to COX2 induces a slow structural transition of the enzyme that results in its selective inactivation.

PubMed Disclaimer

References

    1. Nat New Biol. 1971 Jun 23;231(25):232-5 - PubMed
    1. J Biol Chem. 1962 Oct;237:3245-9 - PubMed
    1. Nature. 1980 Mar 20;284(5753):271-3 - PubMed
    1. Biochemistry. 1982 Mar 2;21(5):1028-32 - PubMed
    1. J Biol Chem. 1985 Oct 15;260(23):12572-8 - PubMed